Substituted oxindole derivatives as tyrosine kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S277700, C548S138000, C548S483000, C548S484000, C514S363000, C514S418000

Reexamination Certificate

active

07071217

ABSTRACT:
The present invention is related to oxindole derivatives of structure (I), compositions containing the same, and methods of use and manufacture of the same. Such compounds generally are useful pharmacologically as agents in those disease states alleviated by the alteration of mitogen activated signaling pathways in general, and in particular in the inhibition or antagonism of protein kinases, which pathologically involve aberrant cellular proliferation. Such disease states include tumor growth, restenosis, atherosclerosis, pain and thrombosis, In particular, the present invention relates to a series of substituted oxindole compounds, which exhibit Trk family protein tyrosine kinase inhibition, and which are useful in cancer therapy and chronic pain indications.

REFERENCES:
patent: 6269086 (2001-07-01), Magana et al.
patent: 6350747 (2002-02-01), Glennon et al.
patent: 6369086 (2002-04-01), Davis et al.
patent: 6387919 (2002-05-01), Davis et al.
patent: 6492398 (2002-12-01), Vyas
patent: 6498176 (2002-12-01), Lackey et al.
patent: 6541503 (2003-04-01), Davis et al.
patent: 6620818 (2003-09-01), Davis
patent: 6624171 (2003-09-01), Harris et al.
patent: 198 24 922 (1999-12-01), None
patent: 99/15500 (1999-04-01), None
patent: 00/56710 (2000-09-01), None
patent: 03/027111 (2003-04-01), None
Zhu, et al 1999, Journal of Clinical Oncology, 17(8), 2419-2428.
Mendell, L, Pain Supplement 1999, 6, 5127-5132.
Nakagawara, Akira, 2001, 169, 107-114.
Wood, J, Am. J. Physiol Gastroinest Liver Physiiolog, 2000, 278, G507-G512.
Kamel. Mohamed et al., “Monoazo metal complex forming dyes. V. Dyes derived from isatin,”Chemical Abstracts.vol. 67, No. 8, abstract No. 33812 (Aug. 21, 1967.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted oxindole derivatives as tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted oxindole derivatives as tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted oxindole derivatives as tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3590910

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.